Healthcare Value Capital as of March 31, 2015
Portfolio Holdings for Healthcare Value Capital
Healthcare Value Capital holds 27 positions in its portfolio as reported in the March 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| AstraZeneca (AZN) | 18.6 | $17M | 250k | 68.43 | |
| Albany Molecular Research | 12.7 | $12M | 662k | 17.60 | |
| Teva Pharmaceutical Industries (TEVA) | 10.2 | $9.3M | 150k | 62.30 | |
| Ultra Short Russell 2000 | 7.8 | $7.1M | 200k | 35.60 | |
| Quest Diagnostics Incorporated (DGX) | 6.5 | $5.9M | 77k | 76.84 | |
| Pfizer (PFE) | 5.7 | $5.2M | 150k | 34.79 | |
| Proshares Tr ultsh nasd biot | 4.7 | $4.3M | 125k | 34.52 | |
| Qlt | 4.5 | $4.2M | 1.1M | 3.91 | |
| Ligand Pharmaceuticals In (LGND) | 4.2 | $3.9M | 50k | 77.12 | |
| Sanofi-Aventis SA (SNY) | 3.5 | $3.2M | 65k | 49.45 | |
| Actavis | 3.2 | $3.0M | 10k | 297.60 | |
| MannKind Corporation | 2.8 | $2.6M | 500k | 5.20 | |
| CryoLife (AORT) | 2.5 | $2.3M | 221k | 10.37 | |
| Ariad Pharmaceuticals | 2.2 | $2.1M | 250k | 8.24 | |
| Sorrento Therapeutics (SRNEQ) | 1.6 | $1.4M | 125k | 11.56 | |
| Alliqua | 1.1 | $1.0M | 196k | 5.20 | |
| Sunesis Pharmaceuticals | 1.1 | $980k | 400k | 2.45 | |
| Amarin Corporation (AMRN) | 1.0 | $936k | 400k | 2.34 | |
| Apricus Bioscience | 1.0 | $935k | 500k | 1.87 | |
| Alimera Sciences | 0.8 | $753k | 150k | 5.02 | |
| Fibrocell Science | 0.8 | $712k | 158k | 4.51 | |
| Zogenix | 0.8 | $685k | 500k | 1.37 | |
| Cytokinetics (CYTK) | 0.7 | $678k | 100k | 6.78 | |
| Aegerion Pharmaceuticals | 0.7 | $654k | 25k | 26.16 | |
| Rigel Pharmaceuticals (RIGL) | 0.6 | $536k | 150k | 3.57 | |
| D Stemline Therapeutics | 0.4 | $362k | 25k | 14.48 | |
| Celsion Corporation | 0.2 | $214k | 80k | 2.68 |
